Capital Market Strategies LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Market Strategies LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.8% during the 4th quarter, Holdings Channel reports. The fund owned 1,237 shares of the medical equipment provider’s stock after buying an additional 90 shares during the quarter. Capital Market Strategies LLC’s holdings in Intuitive Surgical were worth $646,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Mirador Capital Partners LP boosted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Exome Asset Management LLC lifted its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Consolidated Planning Corp increased its stake in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the period. Finally, Swiss National Bank lifted its stake in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after purchasing an additional 3,400 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $5.75 during trading on Monday, hitting $541.05. 425,061 shares of the stock were exchanged, compared to its average volume of 856,272. The stock has a market cap of $192.71 billion, a price-to-earnings ratio of 86.99, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The firm’s 50-day moving average price is $532.76 and its 200 day moving average price is $491.43. Intuitive Surgical, Inc. has a 12-month low of $324.12 and a 12-month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on ISRG shares. Robert W. Baird raised their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.